Department of Pharmacology, Sinhgad College of Pharmacy, Pune - 411 041, India.
Indian J Pharmacol. 2010 Jun;42(3):129-34. doi: 10.4103/0253-7613.66833.
Diabetic neuropathy (DN) is a multifactor complication of diabetes. It is a late finding in type 1 diabetes, but can be an early finding in type 2 diabetes. The cause of DN is still unclear and, like other complications of diabetes, it may be the result of various pathological conditions. Animal models and biomarkers of DN have been extensively used in neuropathic research. The most useful model of DN should exhibit the key feature present in human pathology. Diabetic rodents show behavioral, functional, structural and molecular biomarkers and they are widely used as models to investigate the etiology of DN as well as to screen the efficacy of the potential therapeutic interventions. We have reviewed the different animal models and biomarkers of neuropathy in diabetic rodents of either type 1 or type 2 diabetes.
糖尿病神经病变(DN)是糖尿病的一种多因素并发症。它是 1 型糖尿病的晚期发现,但在 2 型糖尿病中可能是早期发现。DN 的病因尚不清楚,与糖尿病的其他并发症一样,它可能是多种病理状况的结果。DN 的动物模型和生物标志物已广泛应用于神经病变研究。最有用的 DN 模型应该表现出人类病理学中存在的关键特征。糖尿病啮齿动物表现出行为、功能、结构和分子生物标志物,它们被广泛用作研究 DN 病因以及筛选潜在治疗干预措施疗效的模型。我们回顾了 1 型或 2 型糖尿病的糖尿病啮齿动物的不同神经病变动物模型和生物标志物。